$COMM, $DELL, $FRPT, $GHDX, $JYNT, $ORCL, $TSLA
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Friday follows:
CommScope Holding Company, Inc. (NASDAQ:COMM) was raised to Buy from Neutral but the price target was lowered to 19 from 20 at Goldman Sachs.
Dell Technologies Inc. (NYSE:DELL) was started as Buy and was assigned a 62 price target at Deutsche Bank. The firm noted that Dell’s risks of a slowdown in IT-infrastructure growth appears to already be priced into the shares after a recent 25% pullback.
Freshpet, Inc. (NASDAQ:FRPT) was started as Buy and was assigned a 60 target price at DA Davidson.
Genomic Health, Inc. (NASDAQ:GHDX) was raised to Overweight from Neutral with a 72 target price at Piper Jaffray.
The Joint Corporation (NASDAQ:JYNT) was started as Buy and was given a23 target price at B. Riley.
Oracle Corporation (NYSE:ORCL) was last seen up 6% at $55.92 and challenging all-time highs after beating earnings expectations and guiding for double-digit earnings growth based on its on-premise IT offerings, cloud and license support services all contributing to revenue growth. Wedbush Securities maintained its Neutral rating and $55 target price as the firm said it remains on the sidelines as it doesn’t see an inflection point in its infrastructure or cloud position
Tesla Inc. (NASDAQ:TSLA) was reiterated as Sell at Goldman Sachs, and the firm lowered its price target to 158 from 200. The firm sees a lower probability that upside volume scenarios will be achieved. Our call is 140 then 75 then bankruptcy.
Have a terrific weekend.
